Cochrane Reviews and Protocols related to Complementary Medicine

Here is a list, in alphabetical order, of the reviews and protocols that we have assessed as related to complementary or integrative medicine, which are currently available in the Cochrane Library.

Complementary-medicine related Cochrane reviews as of Issue 8 2020 of the Cochrane Library

1. Acanthopanax for acute ischaemic stroke
2. Acetyl-l-carnitine for dementia
3. Acetyl‐L‐carnitine for patients with hepatic encephalopathy
4. Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
5. Acupuncture and acupressure for premenstrual syndrome
6. Acupuncture and assisted reproductive technology
7. Acupuncture and dry-needling for low back pain
8. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis
9. Acupuncture and related interventions for smoking cessation
10. Acupuncture and related interventions for symptoms of chronic kidney disease
11. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome
12. Acupuncture for acute hordeolum
13. Acupuncture for acute management and rehabilitation of traumatic brain injury
14. Acupuncture for acute stroke
15. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
16. Acupuncture for autism spectrum disorders (ASD)
17. Acupuncture for Bell's palsy
18. Acupuncture for cancer pain in adults
19. Acupuncture for chronic asthma
20. Acupuncture for chronic hepatitis B
21. Acupuncture for depression
22. Acupuncture for dysmenorrhoea
23. Acupuncture for dysphagia in acute stroke
24. Acupuncture for epilepsy
25. Acupuncture for functional dyspepsia
26. Acupuncture for glaucoma
27. Acupuncture for hip osteoarthritis
28. Acupuncture for hypertension
29. Acupuncture for hypoxic ischemic encephalopathy in neonates
30. Acupuncture for insomnia
31. Acupuncture for lateral elbow pain
32. Acupuncture for menopausal hot flushes
33. Acupuncture for mumps in children
34. Acupuncture for neuropathic pain in adults
35. Acupuncture for pain in endometriosis
36. Acupuncture for polycystic ovarian syndrome
37. Acupuncture for renal colic
38. Acupuncture for restless legs syndrome
39. Acupuncture for schizophrenia
40. Acupuncture for shoulder pain
41. Acupuncture for slowing the progression of myopia in children and adolescents
42. Acupuncture for stress urinary incontinence in adults
43. Acupuncture for stroke rehabilitation
44. Acupuncture for symptomatic gastroparesis
45. Acupuncture for the prevention of episodic migraine
46. Acupuncture for treating acute ankle sprains in adults
47. Acupuncture for treating fibromyalgia
48. Acupuncture for treatment of irritable bowel syndrome
49. Acupuncture for uterine fibroids
50. Acupuncture for vascular dementia
51. Acupuncture or acupressure for induction of labour
52. Acupuncture or acupressure for pain management during labour
53. Alexander technique for chronic asthma
54. Aloe vera for prevention and treatment of infusion phlebitis
55. Aloe vera for treating acute and chronic wounds
56. Alpha lipoic acid for dementia
57. Altered dietary salt for preventing pre-eclampsia, and its complications
58. Altered dietary salt intake for people with chronic kidney disease
59. Altered dietary salt intake for preventing and treating diabetic kidney disease
60. Alternating current cranial electrotherapy stimulation (CES) for depression
61. Animal‐assisted therapy for dementia
62. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
63. Antenatal breast milk expression by women with diabetes for improving infant outcomes
64. Anti-spasticity agents for multiple sclerosis
65. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
66. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood
67. Antioxidant supplementation for lung disease in cystic fibrosis
68. Antioxidant supplements for liver diseases
69. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
70. Antioxidant supplements for preventing gastrointestinal cancers
71. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
72. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
73. Antioxidant treatments for schizophrenia
74. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
75. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
76. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract
77. Antioxidants for chronic kidney disease
78. Antioxidants for female subfertility
79. Antioxidants for male subfertility
80. Antioxidants for pain in chronic pancreatitis
81. Antioxidants for preventing and reducing muscle soreness after exercise
82. Antioxidants for preventing pre-eclampsia
83. Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
84. Aromatherapy for dementia
85. Aromatherapy for pain management in labour
86. Aromatherapy for treatment of postoperative nausea and vomiting
87. Art therapy for people with dementia
88. Art therapy for schizophrenia or schizophrenia-like illnesses
89. Assessment and support during early labour for improving birth outcomes
90. Assisted reproductive technology: an overview of Cochrane Reviews
91. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
92. Auricular acupuncture for cocaine dependence
93. Ayurvedic medicine for schizophrenia
94. Ayurvedic treatments for diabetes mellitus
95. Balneotherapy for chronic venous insufficiency
96. Balneotherapy for osteoarthritis
97. Balneotherapy for rheumatoid arthritis
98. Behavioural interventions for dysmenorrhoea
99. Behavioural therapies versus other psychological therapies for depression
100. Behavioural treatment for chronic low-back pain
101. Beta-sitosterols for benign prostatic hyperplasia
102. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults
103. Biofeedback for pain management during labour
104. Biofeedback for treatment of chronic idiopathic constipation in adults
105. Biofeedback for treatment of irritable bowel syndrome
106. Black cohosh (Cimicifuga spp.) for menopausal symptoms
107. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
108. Branched-chain amino acids for people with hepatic encephalopathy
109. Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour
110. Breathing exercises for adults with asthma
111. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
112. Caffeine as an analgesic adjuvant for acute pain in adults
113. Caffeine for asthma
114. Caffeine versus theophylline for apnea in preterm infants
115. Calcium and phosphorus supplementation of human milk for preterm infants
116. Calcium and vitamin D for corticosteroid-induced osteoporosis
117. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
118. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
119. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
120. Calcium supplementation for improving bone mineral density in children
121. Calcium supplementation for the management of primary hypertension in adults
122. Calcium supplementation on bone loss in postmenopausal women
123. Calcium, vitamin D or recombinant parathyroid hormone for managing post‐thyroidectomy hypoparathyroidism
124. Calorie controlled diet for chronic asthma
125. Cannabinoids for epilepsy
126. Cannabinoids for fibromyalgia
127. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
128. Cannabinoids for the treatment of dementia
129. Cannabinoids for Tourette's Syndrome
130. Cannabis and schizophrenia
131. Cannabis for the treatment of Crohn's disease
132. Cannabis for the treatment of ulcerative colitis
133. Cannabis‐based medicines for chronic neuropathic pain in adults
134. Cardioprotective interventions for cancer patients receiving anthracyclines
135. Carnitine for fatigue in multiple sclerosis
136. Carnitine supplementation for inborn errors of metabolism
137. Carnitine supplementation for preterm infants with recurrent apnoea
138. Carnitine supplementation of parenterally fed neonates
139. Castor oil, bath and/or enema for cervical priming and induction of labour
140. Cephalic version by moxibustion for breech presentation
141. Chelation therapy for atherosclerotic cardiovascular disease
142. Chinese herbal medicine for atopic eczema
143. Chinese herbal medicine for chronic neck pain due to cervical degenerative disc disease
144. Chinese herbal medicine for diabetic peripheral neuropathy
145. Chinese herbal medicine for endometriosis
146. Chinese herbal medicine for menopausal symptoms
147. Chinese herbal medicine for oesophageal cancer
148. Chinese herbal medicine for premenstrual syndrome
149. Chinese herbal medicine for primary dysmenorrhoea
150. Chinese herbal medicine for schizophrenia
151. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
152. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
153. Chinese herbal medicine in the treatment of ectopic pregnancy
154. Chinese herbal medicine suxiao jiuxin wan for angina pectoris
155. Chinese herbal medicines for acute pancreatitis
156. Chinese herbal medicines for benign thyroid nodules in adults
157. Chinese herbal medicines for esophageal cancer
158. Chinese herbal medicines for hypercholesterolemia
159. Chinese herbal medicines for hyperthyroidism
160. Chinese herbal medicines for hypertriglyceridaemia
161. Chinese herbal medicines for hypothyroidism
162. Chinese herbal medicines for induction of remission in advanced or late gastric cancer
163. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
164. Chinese herbal medicines for threatened miscarriage
165. Chinese herbal medicines for treating osteoporosis
166. Chinese herbal medicines for treating pre-eclampsia
167. Chinese herbal medicines for treating skin and soft-tissue infections
168. Chinese herbal medicines for type 2 diabetes mellitus
169. Chinese herbal medicines for unexplained recurrent miscarriage
170. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
171. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
172. Chinese medicinal herbs for acute bronchitis
173. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
174. Chinese medicinal herbs for cholelithiasis
175. Chinese medicinal herbs for chronic hepatitis B
176. Chinese medicinal herbs for influenza
177. Chinese medicinal herbs for measles
178. Chinese medicinal herbs for mumps
179. Chinese medicinal herbs for sore throat
180. Chinese medicinal herbs for the common cold
181. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients
182. Chitosan for overweight or obesity
183. Chondroitin for osteoarthritis
184. Chromium picolinate supplementation for overweight or obese adults
185. Chuanxiong-type preparations for acute ischemic stroke
186. Cinnamon for diabetes mellitus
187. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease
188. Coenzyme Q10 for heart failure
189. Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
190. Cognitive behavioural therapy for tinnitus
191. Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise
192. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
193. Combined chiropractic interventions for low-back pain
194. Combined diet and exercise interventions for preventing gestational diabetes mellitus
195. Combined vitamin B6-magnesium treatment in autism spectrum disorder
196. Complementary and alternative therapies for pain management in labour
197. Complementary and miscellaneous interventions for nocturnal enuresis in children
198. Complementary therapies for acne vulgaris
199. Conservative interventions for treating exercise-related musculotendinous, ligamentous and osseous groin pain
200. Conservative interventions for treating functional daytime urinary incontinence in children
201. Conservative management for postprostatectomy urinary incontinence
202. Continuous support for women during childbirth
203. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
204. Cranberries for preventing urinary tract infections
205. Cranberries for treating urinary tract infections
206. Creatine for amyotrophic lateral sclerosis/motor neuron disease
207. Creatine for Parkinson's disease
208. Creatine for treating muscle disorders
209. Creatine for women in pregnancy for neuroprotection of the fetus
210. Curcumin for maintenance of remission in ulcerative colitis
211. Cyclamen europaeum extract for acute sinusitis
212. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
213. Daily oral iron supplementation during pregnancy
214. Dan Shen agents for acute ischaemic stroke
215. Dance movement therapy for dementia
216. Dance movement therapy for depression
217. Dance therapy for schizophrenia
218. Dance/movement therapy for improving psychological and physical outcomes in cancer patients
219. Danshen (Chinese medicinal herb) preparations for acute myocardial infarction
220. Deep brain and cortical stimulation for epilepsy
221. Deep transverse friction massage for treating tendinitis
222. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people
223. Dehydroepiandrosterone for systemic lupus erythematosus
224. Dehydroepiandrosterone for women in the peri- or postmenopausal phase
225. Dengzhanhua preparations for acute cerebral infarction
226. Diaries for recovery from critical illness
227. Dietary advice for reducing cardiovascular risk
228. Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
229. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
230. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
231. Dietary fibre for the primary prevention of cardiovascular disease
232. Dietary flavonoid for preventing colorectal neoplasms
233. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia
234. Dietary interventions for adult cancer survivors
235. Dietary interventions for adults with chronic kidney disease
236. Dietary interventions for multiple sclerosis
237. Dietary interventions for multiple sclerosis‐related outcomes
238. Dietary interventions for preventing complications in idiopathic hypercalciuria
239. Dietary interventions for recurrent abdominal pain in childhood
240. Dietary interventions for rheumatoid arthritis
241. Dietary marine fatty acids (fish oil) for asthma in adults and children
242. Dietary sodium manipulation and asthma
243. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes
244. Dietary supplements for chronic gout
245. Dietary supplements for dysmenorrhoea
246. Dietary supplements for established atopic eczema
247. Dietary supplements for preventing postnatal depression
248. Different methods for the induction of labour in outpatient settings
249. Different types of dietary advice for women with gestational diabetes mellitus
250. Drama therapy for schizophrenia or schizophrenia-like illnesses
251. Drugs for preventing lung cancer in healthy people
252. Early intervention for psychosis
253. Early skin-to-skin contact for mothers and their healthy newborn infants
254. Echinacea for preventing and treating the common cold
255. Effect of cocoa on blood pressure
256. Effects and safety of periconceptional folate supplementation for preventing birth defects
257. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
258. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome
259. Effects of total fat intake on body fatness in adults
260. Effects of total fat intake on bodyweight in children
261. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
262. Electrical stimulation for faecal incontinence in adults
263. Electrical stimulation for preventing and treating post-stroke shoulder pain
264. Electrical stimulation for the treatment of rheumatoid arthritis
265. Electrical stimulation for treating pressure ulcers
266. Electrical stimulation with non-implanted electrodes for overactive bladder in adults
267. Electrical stimulation with non-implanted electrodes for urinary incontinence in men
268. Electromagnetic fields for treating osteoarthritis
269. Electromagnetic therapy for treating pressure ulcers
270. Electromagnetic therapy for treating venous leg ulcers
271. Electrotherapy modalities for adhesive capsulitis (frozen shoulder)
272. Endometriosis: an overview of Cochrane Reviews
273. Enteral iron supplementation in preterm and low birth weight infants
274. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
275. Enteral nutrition for maintenance of remission in Crohn's disease
276. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
277. Exercise for dysmenorrhoea
278. Exercise for preventing falls in older people living in the community
279. Exercise for rheumatoid arthritis of the hand
280. Exercise programs for people with dementia
281. Exercises for mechanical neck disorders
282. Fat supplementation of human milk for promoting growth in preterm infants
283. Fermented milk for hypertension
284. Feverfew for preventing migraine
285. Fish oil for induction of remission in ulcerative colitis
286. Fish oil for kidney transplant recipients
287. Flavonoids for treating venous leg ulcers
288. Folate for depressive disorders
289. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
290. Folic acid for fragile X syndrome
291. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes
292. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
293. Ganoderma lucidum (Reishi mushroom) for cancer treatment
294. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
295. Garlic for peripheral arterial occlusive disease
296. Garlic for preventing pre-eclampsia and its complications
297. Garlic for the common cold
298. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
299. Ginkgo biloba extract for age-related macular degeneration
300. Ginkgo biloba for acute ischaemic stroke
301. Ginkgo biloba for cognitive impairment and dementia
302. Ginkgo biloba for intermittent claudication
303. Ginseng for cognition
304. Glucosamine therapy for treating osteoarthritis
305. Glutamine supplementation for critically ill adults
306. Glutamine supplementation for young infants with severe gastrointestinal disease
307. Glutamine supplementation to prevent morbidity and mortality in preterm infants
308. Green and black tea for the primary prevention of cardiovascular disease
309. Green tea (Camellia sinensis) for the prevention of cancer
310. Green tea for weight loss and weight maintenance in overweight or obese adults
311. Guided imagery for treating hypertension in pregnancy
312. Hawthorn extract for treating chronic heart failure
313. Helminth therapy (worms) for allergic rhinitis
314. Helminth therapy (worms) for induction of remission in inflammatory bowel disease
315. Herbal interventions for chronic asthma in adults and children
316. Herbal medicinal products or preparations for neuropathic pain
317. Herbal medicine for low-back pain
318. Herbal medicines for fatty liver diseases
319. Herbal medicines for treating HIV infection and AIDS
320. Herbal medicines for treatment of irritable bowel syndrome
321. Herbal preparations for uterine fibroids
322. Herbal therapy for treating rheumatoid arthritis
323. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
324. Homeopathic medicines for adverse effects of cancer treatments
325. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness
326. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
327. Homeopathy for chronic asthma
328. Homeopathy for dementia
329. Homeopathy for treatment of irritable bowel syndrome
330. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
331. Homocysteine-lowering interventions for preventing cardiovascular events
332. Homoeopathy for induction of labour
333. Honey and lozenges for children with non-specific cough
334. Honey as a topical treatment for wounds
335. Honey for acute cough in children
336. Horse chestnut seed extract for chronic venous insufficiency
337. Horticultural therapy for schizophrenia
338. Huperzine A for Alzheimer's disease
339. Huperzine A for mild cognitive impairment
340. Huperzine A for vascular dementia
341. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
342. Hyperbaric oxygen therapy for acute coronary syndrome
343. Hyperbaric oxygen therapy for acute ischaemic stroke
344. Hyperbaric oxygen therapy for Bell's palsy
345. Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury
346. Hyperbaric oxygen therapy for multiple sclerosis
347. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD)
348. Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
349. Hyperbaric oxygen therapy for vascular dementia
350. Hyperbaric oxygenation for tumour sensitisation to radiotherapy
351. Hypnosis during pregnancy, childbirth, and the postnatal period for preventing postnatal depression
352. Hypnosis for induction of labour
353. Hypnosis for schizophrenia
354. Hypnotherapy for smoking cessation
355. Hypnotherapy for treatment of irritable bowel syndrome
356. Immersion in water during labour and birth
357. Immunonutrition as an adjuvant therapy for burns
358. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
359. Immunonutrition for patients undergoing surgery for head and neck cancer
360. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases
361. Inositol for depressive disorders
362. Inositol for subfertile women with polycystic ovary syndrome
363. Inositol in preterm infants at risk for or having respiratory distress syndrome
364. Intercessory prayer for the alleviation of ill health
365. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
366. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews
367. Interventions for apathy after traumatic brain injury
368. Interventions for bone disease in children with chronic kidney disease
369. Interventions for bullous pemphigoid
370. Interventions for chronic kidney disease-associated restless legs syndrome
371. Interventions for chronic palmoplantar pustulosis
372. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy
373. Interventions for cutaneous molluscum contagiosum
374. Interventions for drug‐using offenders with co‐occurring mental health problems
375. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury
376. Interventions for erosive lichen planus affecting mucosal sites
377. Interventions for fatigue in inflammatory bowel disease
378. Interventions for fatigue in peripheral neuropathy
379. Interventions for improving mobility after hip fracture surgery in adults
380. Interventions for improving sleep quality in people with chronic kidney disease
381. Interventions for improving upper limb function after stroke
382. Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment
383. Interventions for ingrowing toenails
384. Interventions for lowering plasma homocysteine levels in dialysis patients
385. Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
386. Interventions for managing asthma in pregnancy
387. Interventions for managing taste disturbances
388. Interventions for nausea and vomiting in early pregnancy
389. Interventions for pityriasis rosea
390. Interventions for preventing and treating pelvic and back pain in pregnancy
391. Interventions for preventing bone disease in kidney transplant recipients
392. Interventions for preventing falls in older people in care facilities and hospitals
393. Interventions for preventing falls in older people living in the community
394. Interventions for preventing falls in people after stroke
395. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological interventions
396. Interventions for preventing infection in nephrotic syndrome
397. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section
398. Interventions for preventing oral mucositis for patients with cancer receiving treatment
399. Interventions for prevention of post-operative recurrence of Crohn's disease
400. Interventions for primary vesicoureteric reflux
401. Interventions for prodromal stage of psychosis
402. Interventions for reducing anxiety in women undergoing colposcopy
403. Interventions for reducing inflammation in familial Mediterranean fever
404. Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants
405. Interventions for the management of dry mouth: non-pharmacological interventions
406. Interventions for the management of oral submucous fibrosis
407. Interventions for the management of temporomandibular joint osteoarthritis
408. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
409. Interventions for treating anxiety after stroke
410. Interventions for treating burning mouth syndrome
411. Interventions for treating collagenous colitis
412. Interventions for treating constipation in pregnancy
413. Interventions for treating hyperemesis gravidarum
414. Interventions for treating leg ulcers in people with sickle cell disease
415. Interventions for treating oral leukoplakia to prevent oral cancer
416. Interventions for treating painful nipples among breastfeeding women
417. Interventions for treating persistent pain in survivors of torture
418. Interventions for treating sexual dysfunction in patients with chronic kidney disease
419. Interventions for treating urinary incontinence after stroke in adults
420. Interventions to facilitate return to work in adults with adjustment disorders
421. Interventions to improve psychosocial well‐being in female BRCA‐mutation carriers following risk‐reducing surgery
422. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews
423. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
424. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
425. Iodine supplementation for women during the preconception, pregnancy and postpartum period
426. Iron chelators for acute stroke
427. Iron for the treatment of restless legs syndrome
428. Iron supplementation for breath-holding attacks in children
429. Iron supplementation for reducing morbidity and mortality in children with HIV
430. Isoflavones for hypercholesterolaemia in adults
431. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
432. Kava extract versus placebo for treating anxiety
433. Ketogenic diets for drug‐resistant epilepsy
434. L-carnitine for cognitive enhancement in people without cognitive impairment
435. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
436. Lactose avoidance for young children with acute diarrhoea
437. Laetrile treatment for cancer
438. Lecithin for dementia and cognitive impairment
439. Lifestyle interventions for acute gout
440. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
441. Light therapy for non-seasonal depression
442. Light therapy for preventing seasonal affective disorder
443. Lipid emulsions for parenterally fed preterm infants
444. Lipid emulsions for parenterally fed term and late preterm infants
445. Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes
446. Local cooling for relieving pain from perineal trauma sustained during childbirth
447. Long chain polyunsaturated fatty acid supplementation in infants born at term
448. Longchain polyunsaturated fatty acid supplementation in preterm infants
449. Low glycaemic index diets for the prevention of cardiovascular disease
450. Low glycaemic index or low glycaemic load diets for overweight and obesity
451. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
452. Low protein diets for non‐diabetic adults with chronic kidney disease
453. Low-fat diets for acquired hypercholesterolaemia
454. Lycopene for the prevention of prostate cancer
455. Magnesium for alcohol withdrawal
456. Magnesium for skeletal muscle cramps
457. Magnesium for treating sickle cell disease
458. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
459. Magnesium supplementation for the management of primary hypertension in adults
460. Magnesium supplementation in pregnancy
461. Mailuoning for acute ischaemic stroke
462. Management of gag reflex for patients undergoing dental treatment
463. Manipulative therapies for infantile colic
464. Manual therapy and exercise for adhesive capsulitis (frozen shoulder)
465. Manual therapy for asthma
466. Marine‐derived n‐3 fatty acids therapy for stroke
467. Massage and touch for dementia
468. Massage for low-back pain
469. Massage for mechanical neck disorders
470. Massage for promoting growth and development of preterm and/or low birth-weight infants
471. Massage for promoting mental and physical health in typically developing infants under the age of six months
472. Massage therapy for people with HIV/AIDS
473. Massage with or without aromatherapy for symptom relief in people with cancer
474. Massage, reflexology and other manual methods for pain management in labour
475. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child
476. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants
477. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
478. Medicinal herbs for hepatitis C virus infection
479. Meditation for adults with haematological malignancies
480. Meditation therapies for attention-deficit/hyperactivity disorder (ADHD)
481. Meditation therapy for anxiety disorders
482. Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
483. Melatonin and agomelatine for preventing seasonal affective disorder
484. Melatonin as add-on treatment for epilepsy
485. Melatonin for non-respiratory sleep disorders in visually impaired children
486. Melatonin for the prevention and treatment of jet lag
487. Melatonin for the promotion of sleep in adults in the intensive care unit
488. Melatonin for the treatment of dementia
489. Melatonin for women in pregnancy for neuroprotection of the fetus
490. Methods of milk expression for lactating women
491. Micronutrient supplementation in adults with HIV infection
492. Micronutrient supplementation in pregnant women with HIV infection
493. Midwife-led continuity models versus other models of care for childbearing women
494. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
495. Mind-body interventions during pregnancy for preventing or treating women's anxiety
496. Mindfulness‐based stress reduction for family carers of people with dementia
497. Mindfulness‐based stress reduction for women diagnosed with breast cancer
498. Mistletoe therapy in oncology
499. Momordica charantia for type 2 diabetes mellitus
500. Monosodium glutamate avoidance for chronic asthma in adults and children
501. Morita therapy for anxiety disorders in adults
502. Morita therapy for schizophrenia
503. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer
504. Multinutrient fortification of human breast milk for preterm infants following hospital discharge
505. Muscle energy technique for non-specific low-back pain
506. Music during caesarean section under regional anaesthesia for improving maternal and infant outcomes
507. Music for stress and anxiety reduction in coronary heart disease patients
508. Music interventions for acquired brain injury
509. Music interventions for improving psychological and physical outcomes in cancer patients
510. Music interventions for mechanically ventilated patients
511. Music interventions for preoperative anxiety
512. Music therapy for depression
513. Music therapy for people with autism spectrum disorder
514. Music therapy for people with schizophrenia and schizophrenia-like disorders
515. Music‐based therapeutic interventions for people with dementia
516. N-acetylcarnosine (NAC) drops for age-related cataract
517. N‐acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
518. Neuromodulators for pain management in rheumatoid arthritis
519. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
520. Neuromuscular electrical stimulation for the prevention of venous thromboembolism
521. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
522. Niacin for primary and secondary prevention of cardiovascular events
523. Nicotine for schizophrenia
524. Nidotherapy for people with schizophrenia
525. Non surgical therapy for anal fissure
526. Non-clinical interventions for reducing unnecessary caesarean section
527. Non-drug therapies for lower limb muscle cramps
528. Non-hormonal interventions for hot flushes in women with a history of breast cancer
529. Non-invasive brain stimulation techniques for chronic pain
530. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer
531. Non-pharmacological interventions for alleviating pain during orthodontic treatment
532. Non-pharmacological interventions for chronic pain in people with spinal cord injury
533. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment
534. Non-pharmacological interventions for epilepsy in people with intellectual disabilities
535. Non-pharmacological interventions for fatigue in rheumatoid arthritis
536. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults
537. Non-surgical interventions for the management of chronic pelvic pain
538. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome
539. Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
540. Non‐clinical interventions for reducing unnecessary caesarean section
541. Non‐pharmacological interventions for chronic pain in multiple sclerosis
542. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache
543. Nutrient-enriched formula milk versus human breast milk for preterm infants following hospital discharge
544. Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge
545. Nutritional interventions for liver-transplanted patients
546. Nutritional interventions for preventing and treating pressure ulcers
547. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy
548. Nutritional interventions for reducing morbidity and mortality in people with HIV
549. Nutritional interventions for survivors of childhood cancer
550. Nutritional interventions for treating foot ulcers in people with diabetes
551. Nutritional supplementation for hip fracture aftercare in older people
552. Nutritional supplementation for stable chronic obstructive pulmonary disease
553. Nutritional supplements for patients being treated for active visceral leishmaniasis
554. Nutritional supplements for people being treated for active tuberculosis
555. Nutritional support for acute kidney injury
556. Nutritional support for liver disease
557. Omega 3 fatty acid for the prevention of cognitive decline and dementia
558. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
559. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis
560. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration
561. Omega-3 fatty acids for bipolar disorder
562. Omega-3 fatty acids for the treatment of dementia
563. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD)
564. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
565. Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease
566. Omega‐3 fatty acid addition during pregnancy
567. Omega‐3 fatty acid supplementation for cystic fibrosis
568. Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
569. Omega‐3 fatty acids for intermittent claudication
570. Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
571. Omega‐6 fats for the primary and secondary prevention of cardiovascular disease
572. Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
573. Oral evening primrose oil and borage oil for eczema
574. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
575. Oral herbal therapies for treating osteoarthritis
576. Oral immunotherapy for milk allergy
577. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
578. Oral protein‐based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis
579. Oral traditional Chinese medication for adhesive small bowel obstruction
580. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
581. Oral zinc for arterial and venous leg ulcers
582. Oral zinc for treating diarrhoea in children
583. Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates
584. Over-the-counter (OTC) medications for acute cough in children and adults in community settings
585. Padma 28 for intermittent claudication
586. Pain management for women in labour: an overview of systematic reviews
587. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment
588. Pain-relieving agents for infantile colic
589. Pancreatic enzymes for chronic pancreatitis
590. Parent-infant psychotherapy for improving parental and infant mental health
591. Parenteral versus oral iron therapy for adults and children with chronic kidney disease
592. Participation in environmental enhancement and conservation activities for health and well-being in adults: a review of quantitative and qualitative evidence
593. Participation of traditional, complementary and alternative health practitioners in conventional health systems in low‐ and middle‐income countries
594. Passiflora for anxiety disorder
595. Pelargonium sidoides extract for treating acute respiratory tract infections
596. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women
597. Perceptions and experiences of labour companionship: a qualitative evidence synthesis
598. Peri-operative glycaemic control regimens for preventing surgical site infections in adults
599. Perianal injectable bulking agents as treatment for faecal incontinence in adults
600. Person-directed, non-pharmacological interventions for sleepiness at work and sleep disturbances caused by shift work
601. Pharmacological agents for adults with acute respiratory distress syndrome
602. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
603. Pharmacological interventions for borderline personality disorder
604. Pharmacological interventions for clozapine-induced hypersalivation
605. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
606. Pharmacological interventions for somatoform disorders in adults
607. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy
608. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome
609. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome
610. Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
611. Pharmacotherapies for cannabis dependence
612. Pharmacotherapies for sleep disturbances in Alzheimer's disease
613. Phlebotonics for haemorrhoids
614. Phlebotonics for venous insufficiency
615. Phyllanthus species for chronic hepatitis B virus infection
616. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
617. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews
618. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
619. Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer
620. Physical therapies for postural abnormalities in people with cystic fibrosis
621. Phytoestrogens for menopausal vasomotor symptoms
622. Phytomedicines (medicines derived from plants) for sickle cell disease
623. Pilates for low back pain
624. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy
625. Polyunsaturated fatty acid supplementation for schizophrenia
626. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
627. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
628. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
629. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants
630. Potassium supplementation for the management of primary hypertension in adults
631. Prebiotics for the prevention of hyperbilirubinaemia in neonates
632. Prebiotics in infants for prevention of allergy
633. Prescribed hypocaloric nutrition support for critically-ill adults
634. Preventing occupational stress in healthcare workers
635. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
636. Probiotics for induction of remission in Crohn's disease
637. Probiotics for induction of remission in ulcerative colitis
638. Probiotics for maintenance of remission in Crohn's disease
639. Probiotics for maintenance of remission in ulcerative colitis
640. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
641. Probiotics for people with cystic fibrosis
642. Probiotics for people with hepatic encephalopathy
643. Probiotics for preventing acute otitis media in children
644. Probiotics for preventing acute upper respiratory tract infections
645. Probiotics for preventing gestational diabetes
646. Probiotics for preventing preterm labour
647. Probiotics for preventing urinary tract infection in people with neuropathic bladder
648. Probiotics for prevention of necrotizing enterocolitis in preterm infants
649. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
650. Probiotics for the prevention of pediatric antibiotic‐associated diarrhea
651. Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer
652. Probiotics for the treatment of bacterial vaginosis
653. Probiotics for the treatment of irritable bowel syndrome in children
654. Probiotics for treating acute infectious diarrhoea
655. Probiotics for treating eczema
656. Probiotics for treating persistent diarrhoea in children
657. Probiotics for treatment of Clostridium difficile-associated colitis in adults
658. Probiotics for vulvovaginal candidiasis in non-pregnant women
659. Probiotics in infants for prevention of allergic disease and food hypersensitivity
660. Probiotics to prevent infantile colic
661. Procaine treatments for cognition and dementia
662. Prolotherapy injections for chronic low-back pain
663. Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants
664. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants
665. Protein restriction for children with chronic kidney disease
666. Protein restriction for diabetic renal disease
667. Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
668. Psychological and behavioural treatments for adults with non-epileptic attack disorder
669. Psychological and educational interventions for atopic eczema in children
670. Psychological interventions for acute pain after open heart surgery
671. Psychological interventions for coronary heart disease
672. Psychological interventions for needle‐related procedural pain and distress in children and adolescents
673. Psychological interventions for people with hemophilia
674. Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
675. Psychological interventions to foster resilience in healthcare professionals
676. Psychological interventions to foster resilience in healthcare students
677. Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia
678. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents
679. Psychological therapies for children and adolescents exposed to trauma
680. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis
681. Psychological therapies for pathological and problem gambling
682. Psychological therapies for people with borderline personality disorder
683. Psychological therapies for preventing seasonal affective disorder
684. Psychological therapies for the management of chronic and recurrent pain in children and adolescents
685. Psychological therapies for the management of chronic pain (excluding headache) in adults
686. Psychological therapies for the prevention of migraine in adults
687. Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
688. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents
689. Psychological therapies for treatment-resistant depression in adults
690. Psychological therapies for women who experience intimate partner violence
691. Psychological treatments for people with epilepsy
692. Psychosocial group interventions to improve psychological well-being in adults living with HIV
693. Psychosocial interventions for conversion and dissociative disorders in adults
694. Psychosocial interventions for preventing and treating depression in dialysis patients
695. Psychosocial interventions for recurrent abdominal pain in childhood
696. Psychosocial interventions for self-harm in adults
697. Puerarin for ischaemic stroke
698. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders
699. Pygeum africanum for benign prostatic hyperplasia
700. Pyridoxine (vitamin B6) supplementation in pregnancy
701. Quinine for muscle cramps
702. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
703. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B
704. Reduced dietary salt for the prevention of cardiovascular disease
705. Reduced or modified dietary fat for preventing cardiovascular disease
706. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy
707. Reduction in saturated fat intake for cardiovascular disease
708. Regimens of vitamin D supplementation for women during pregnancy
709. Rehabilitation following carpal tunnel release
710. Relaxation for depression
711. Relaxation for perimenopausal and postmenopausal symptoms
712. Relaxation techniques for pain management in labour
713. Relaxation therapies for the management of primary hypertension in adults
714. Relaxation therapy for preventing and treating preterm labour
715. Reminiscence therapy for dementia
716. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults
717. Repetitive transcranial magnetic stimulation for improving function after stroke
718. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease
719. Repetitive transcranial magnetic stimulation for tinnitus
720. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
721. Resveratrol for adults with type 2 diabetes mellitus
722. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
723. Roselle for hypertension in adults
724. Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
725. Rutosides for prevention of post‐thrombotic syndrome
726. Rutosides for treatment of post‐thrombotic syndrome
727. S-adenosyl methionine (SAMe) for depression in adults
728. S-adenosyl-L-methionine for alcoholic liver diseases
729. S-Adenosylmethionine for osteoarthritis of the knee or hip
730. Salicylate-containing rubefacients for acute and chronic musculoskeletal pain in adults
731. Sanchi for acute ischaemic stroke
732. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients
733. Selenium for preventing cancer
734. Selenium supplementation for asthma
735. Selenium supplementation for critically ill adults
736. Selenium supplementation for Hashimoto's thyroiditis
737. Selenium supplementation for the primary prevention of cardiovascular disease
738. Selenium supplementation to prevent short-term morbidity in preterm neonates
739. Sensory environment on health-related outcomes of hospital patients
740. Serenoa repens for benign prostatic hyperplasia
741. Simulated presence therapy for dementia
742. Singing as an adjunct therapy for children and adults with cystic fibrosis
743. Singing for adults with chronic obstructive pulmonary disease (COPD)
744. Singing for children and adults with bronchiectasis
745. Single dose oral ibuprofen plus caffeine for acute postoperative pain in adults
746. Single herbal medicine for diabetic retinopathy
747. Skin-to-skin care for procedural pain in neonates
748. Smectite for acute infectious diarrhoea in children
749. Snoezelen for dementia
750. Speleotherapy for asthma
751. Spinal manipulation for dysmenorrhoea
752. Spinal manipulative therapy for acute low-back pain
753. Spinal manipulative therapy for chronic low-back pain
754. Spiritual and religious interventions for well-being of adults in the terminal phase of disease
755. Sports and games for post-traumatic stress disorder (PTSD)
756. St John's wort for major depression
757. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age
758. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting
759. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants
760. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
761. Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement
762. Swallowing therapy for dysphagia in acute and subacute stroke
763. Sweet potato for type 2 diabetes mellitus
764. Tai Chi for chronic obstructive pulmonary disease (COPD)
765. Tai chi for primary prevention of cardiovascular disease
766. Tai Chi for rheumatoid arthritis
767. Tea tree oil for Demodex blepharitis
768. Testosterone for schizophrenia
769. Therapeutic touch for anxiety disorders
770. Therapeutic ultrasound for chronic low back pain
771. Thermotherapy for treating rheumatoid arthritis
772. Thermotherapy for treatment of osteoarthritis
773. Thiamine for Alzheimer's disease
774. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol
775. 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression
776. 'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
777. Thymic peptides for treatment of cancer patients
778. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery
779. Thyroid hormones for acute kidney injury
780. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants
781. Tianma Gouteng Yin Formula for treating primary hypertension
782. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris
783. Tongxinluo capsule for acute stroke
784. Topical analgesia for acute otitis media
785. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews
786. Topical capsaicin (high concentration) for chronic neuropathic pain in adults
787. Topical capsaicin (low concentration) for chronic neuropathic pain in adults
788. Topical herbal therapies for treating osteoarthritis
789. Topical treatments for chronic plaque psoriasis
790. Traditional Chinese herbal medicine for vascular dementia
791. Traditional Chinese herbal products for stable angina
792. Traditional Chinese Medicine herbs for stopping bleeding from haemorrhoids
793. Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
794. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke
795. Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke
796. Transcranial magnetic stimulation for the treatment of epilepsy
797. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder
798. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults
799. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain
800. Transcutaneous Electrical Nerve Stimulation (TENS) for dementia
801. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults
802. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults
803. Transcutaneous electrical nerve stimulation (TENS) for pain management in labour
804. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease
805. Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
806. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand
807. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain
808. Transcutaneous electrical nerve stimulation for acute pain
809. Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
810. Transcutaneous electrical stimulation (TES) for treatment of constipation in children
811. Transcutaneous electrostimulation for osteoarthritis of the knee
812. Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies)
813. Treatment for ataxia in multiple sclerosis
814. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
815. Treatment for mitochondrial disorders
816. Treatment for osteoporosis in people with ß-thalassaemia
817. Treatment for postpolio syndrome
818. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease
819. Treatments for breast engorgement during lactation
820. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
821. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
822. Tryptophan and 5-Hydroxytryptophan for depression
823. Tyrosine supplementation for phenylketonuria
824. Uterine massage for preventing postpartum haemorrhage
825. Valerian for anxiety disorders
826. Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
827. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
828. Vitamin A for non-measles pneumonia in children
829. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
830. Vitamin A for treating measles in children
831. Vitamin A supplementation during pregnancy for maternal and newborn outcomes
832. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
833. Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
834. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants
835. Vitamin A supplements for reducing mother-to-child HIV transmission
836. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
837. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
838. Vitamin B and its derivatives for diabetic kidney disease
839. Vitamin B for treating peripheral neuropathy
840. Vitamin B6 for cognition
841. Vitamin B12 for cognition
842. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy
843. Vitamin C for asthma and exercise-induced bronchoconstriction
844. Vitamin C for preventing and treating pneumonia
845. Vitamin C for preventing and treating tetanus
846. Vitamin C for preventing and treating the common cold
847. Vitamin C supplementation for prevention and treatment of pneumonia
848. Vitamin C supplementation for the primary prevention of cardiovascular disease
849. Vitamin C supplementation in pregnancy
850. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
851. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
852. Vitamin D compounds for people with chronic kidney disease not requiring dialysis
853. Vitamin D compounds for people with chronic kidney disease requiring dialysis
854. Vitamin D for the management of asthma
855. Vitamin D for the management of multiple sclerosis
856. Vitamin D for the treatment of chronic painful conditions in adults
857. Vitamin D supplementation for cystic fibrosis
858. Vitamin D supplementation for improving bone mineral density in children
859. Vitamin D supplementation for preventing infections in children under five years of age
860. Vitamin D supplementation for prevention of cancer in adults
861. Vitamin D supplementation for prevention of mortality in adults
862. Vitamin D supplementation for sickle cell disease
863. Vitamin D supplementation for women during pregnancy
864. Vitamin E for Alzheimer's dementia and mild cognitive impairment
865. Vitamin E for intermittent claudication
866. Vitamin E for neuroleptic-induced tardive dyskinesia
867. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants
868. Vitamin E supplementation in people with cystic fibrosis
869. Vitamin E supplementation in pregnancy
870. Vitamin K for improved anticoagulation control in patients receiving warfarin
871. Vitamin K for upper gastrointestinal bleeding in patients with acute or chronic liver diseases
872. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
873. Vitamin K supplementation for cystic fibrosis
874. Vitamin supplementation for preventing miscarriage
875. Vitamins C and E for asthma and exercise-induced bronchoconstriction
876. Vitamins for epilepsy
877. Water for preventing urinary stones
878. Water for wound cleansing
879. Weight loss interventions for chronic asthma
880. Wendan decoction (Traditional Chinese medicine) for schizophrenia
881. Whole grain cereals for the primary or secondary prevention of cardiovascular disease
882. Whole grain foods for the prevention of type 2 diabetes mellitus
883. Workplace interventions for reducing sitting at work
884. Wound cleansing for pressure ulcers
885. Written emotional disclosure for asthma
886. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
887. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
888. Xuebijing for paraquat poisoning
889. Xylitol for preventing acute otitis media in children up to 12 years of age
890. Yizhi capsule for vascular dementia
891. Yoga as part of a package of care versus non‐standard care for schizophrenia
892. Yoga as part of a package of care versus standard care for schizophrenia
893. Yoga for asthma
894. Yoga for epilepsy
895. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer
896. Yoga for secondary prevention of coronary heart disease
897. Yoga for the primary prevention of cardiovascular disease
898. Yoga for treating urinary incontinence in women
899. Yoga in addition to standard care for patients with haematological malignancies
900. Yoga treatment for chronic non-specific low back pain
901. Yoga versus non-standard care for schizophrenia
902. Yoga versus standard care for schizophrenia
903. Zhiling decoction for vascular dementia
904. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
905. Zinc supplementation for improving pregnancy and infant outcome
906. Zinc supplementation for mental and motor development in children
907. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
908. Zinc supplementation for the prevention of type 2 diabetes mellitus
909. Zinc supplementation for tinnitus
910. Zinc supplements for preventing otitis media
911. Zinc supplements for treating thalassaemia and sickle cell disease

Complementary-medicine related Cochrane protocols as of Issue 8 2020 of the Cochrane Library

1. Abdominal massage for the treatment of constipation
2. Acetyl-L-carnitine for the treatment of diabetic polyneuropathy
3. Acupoint stimulation for postoperative ileus following gastrointestinal surgery
4. Acupuncture for (sub)acute non-specific low-back pain
5. Acupuncture for adults with type 2 diabetes mellitus
6. Acupuncture for angina pectoris
7. Acupuncture for chronic constipation
8. Acupuncture for chronic neck pain
9. Acupuncture for female subfertility
10. Acupuncture for Gilles de la Tourette's syndrome
11. Acupuncture for Guillain-Barré syndrome
12. Acupuncture for Parkinson's Disease
13. Acupuncture for primary hypercholesterolaemia
14. Acupuncture for sudden idiopathic sensorineural hearing loss
15. Acupuncture for symptomatic treatment of diabetic peripheral neuropathy
16. Acupuncture for the prevention of tension-type headache
17. Acupuncture for the treatment of post-operative pain
18. Acupuncture for treating overactive bladder in adults
19. Acupuncture for treatment-related side effects in women with breast cancer
20. Acupuncture for turning a breech baby in pregnancy
21. Acupuncture point stimulation for chronic obstructive pulmonary disease
22. Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia
23. Alcohol intake reduction for controlling hypertension
24. Alpha-lipoic acid for diabetic peripheral neuropathy
25. Alternative prophylactic therapies (acupuncture and/or moxibustion) for reducing blood loss in the third stage of labour
26. Animal-assisted therapy for people with serious mental illness
27. Animal‐assisted therapy, including animal‐assisted activities and resident animals, for improving quality of life in people with stroke
28. Antioxidant supplementation for sickle cell disease
29. Antioxidants for acute pancreatitis
30. Behavioural therapies versus treatment as usual for depression
31. Branched-chain amino acid supplementation for improving nutrition in term and preterm neonates
32. Calcium and vitamin D for increasing bone mineral density in premenopausal women
33. Calcium supplementation for prevention of primary hypertension
34. Calcium supplementation for weight reduction in overweight or obese people
35. Cannabis and cannabinoids for people with multiple sclerosis
36. Capsaicin for non-allergic rhinitis
37. Carbohydrate or fat-restricted diets for obesity
38. Carnitine supplements for people with chronic kidney disease requiring dialysis
39. Chelation for autism spectrum disorder (ASD)
40. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions
41. Chinese herbal medicine for advanced pancreatic cancer
42. Chinese herbal medicine for treating recurrent urinary tract infections in women
43. Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancer
44. Chinese herbal medicines for treating gestational diabetes mellitus
45. Chinese medicinal herbs for vaginal bleeding of medical abortion
46. Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
47. Citicoline (CDP-choline) for traumatic brain injury
48. Cognitive-emotional interventions for breathlessness in adults with advanced diseases
49. Combined large neutral amino acid supplementation for phenylketonuria (PKU)
50. Complementary and alternative therapies for post-caesarean pain
51. Complementary and alternative therapies for shortening labour
52. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
53. Cordyceps sinensis for hypertension in adults
54. Coriolus versicolor mushroom for colorectal cancer treatment
55. Cranberries for treating asymptomatic bacteriuria during pregnancy
56. Dietary advice for schizophrenia
57. Different strains of probiotics for preventing morbidity and mortality in preterm infants: a network meta-analysis
58. EEG neurofeedback for executive functions in children with neurodevelopmental challenges
59. Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease
60. The effects of oral vitamin D supplementation on linear growth and non-communicable diseases among infants and children younger than five years of age
61. Effects of preventive oral supplementation with iron or iron with folic acid for women following childbirth
62. Electrical stimulation with non-implanted devices for stress urinary incontinence in women
63. Electrotherapy modalities for lateral elbow pain
64. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates
65. Ephedrine for myasthenia gravis
66. Essential phospholipids for people with non‐alcoholic fatty liver disease
67. Fecal microbiota transplantation for treatment of irritable bowel syndrome
68. Fiber and bulking agents for the treatment of chronic constipation
69. Fish oil supplements for rheumatoid arthritis
70. Fish oil supplements for the prevention and treatment of hypertension in adults
71. Fish oil-based lipid emulsions versus standard lipid emulsions for prevention of parenteral nutrition-associated liver disease in children
72. Fish oil-based lipid emulsions versus standard lipid emulsions for treatment of parenteral nutrition-associated liver disease in children
73. Folate supplementation in patients with sickle cell disease
74. Folate supplementation in people with sickle cell disease
75. Ginkgo biloba for tinnitus
76. Ginkgo biloba versus placebo for schizophrenia
77. Ginseng for erectile dysfunction
78. Ginseng for improving the quality of life in people with cancer
79. Glutamine for induction of remission in Crohn's disease
80. Glycyrrhizin for chronic hepatitis B virus infection
81. Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection
82. Helminths for asthma
83. Herbal (non‐Chinese) medicines for functional dyspepsia
84. Herbal medicines for systemic lupus erythematosus
85. Herbal medicines for the treatment of inflammatory bowel disease
86. Herbal medicines for type 1 diabetes mellitus
87. Herbal preparations for weight loss in adults
88. Homeopathy for osteoarthritis
89. Humanistic therapies versus other psychological therapies for depression
90. Humanistic therapies versus treatment as usual for depression
91. Humour‐based interventions for people with schizophrenia
92. Hyperbaric oxygen therapy for persistent post-concussion syndrome following mild traumatic brain injury
93. Hypnosis for pain management during labour and childbirth
94. Hypnosis for preventing preterm labour
95. Intermittent fasting for the prevention of cardiovascular disease
96. Interventions (other than psychosocial, psychological and pharmacological) for treating postpartum depression
97. Interventions for helping people recognise early signs of recurrence in depression
98. Intranasal oxytocin for autism spectrum disorders (ASD)
99. Intranasal phototherapy for allergic rhinitis
100. Ketogenic diet for primary brain and spinal cord tumours
101. L-acetylcarnitine for fragile X syndrome
102. Lactoferrin for the post-operative management of term neonates after gastrointestinal surgery
103. Leeches (Hirudinea) for osteoarthritis
104. Listening to music for improving sleep in adults with insomnia
105. Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk
106. Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants
107. Magnesium sulphate for acute bronchiolitis in children under two years of age
108. Magnetic seizure therapy for people with schizophrenia
109. Manual therapy and exercise for lateral elbow pain
110. Manual therapy with exercise for neck pain
111. Marine oil supplements for rheumatoid arthritis
112. Massage therapy for preventing pressure ulcers
113. Maternal antenatal methylxanthine (including caffeine) treatment for improving preterm outcomes
114. Maternal prenatal and/or postnatal n-3 fish oil supplementation for preventing allergies in early childhood
115. The McKenzie method for (sub)acute non-specific low-back pain
116. The McKenzie method for chronic non-specific low-back pain
117. Medicinal herbs for acute hepatitis B
118. Meditation for adult patients with haematological malignancies
119. Meditation for the primary and secondary prevention of cardiovascular disease
120. Melatonin for preoperative anxiety in adults
121. Melatonin for treating pre-eclampsia
122. Melatonin in cancer treatment
123. Mind-body movement therapies for Parkinson's disease
124. Mindfulness for smoking cessation
125. Mindfulness-based parenting programmes for improving psychosocial outcomes in children from birth to age 18 and their parents
126. Modified dietary fat intake for treatment of gallstone disease
127. Moxibustion for stroke rehabilitation
128. Music for pain relief
129. Music therapy for people with substance use disorders
130. Musical and vocal interventions to improve neurodevelopmental outcomes for preterm infants
131. Myo-inositol for preventing gestational diabetes
132. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
133. Neuroaid for improving recovery after ischemic stroke
134. Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome
135. Non-hormonal therapy for hot flushes in postmenopausal women
136. Non-pharmacological interventions for managing dental anxiety in children
137. Non‐invasive brain stimulation for improving cognitive function in people with dementia and mild cognitive impairment
138. Nutritional supplementation for non‐alcohol‐related fatty liver disease: a network meta‐analysis
139. Omega 3 fatty acids for the treatment of dementia and cognitive impairment
140. Omega-3 fatty acids for depression in adults
141. Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease
142. Open Dialogue for psychosis or severe mental illness
143. Oral probiotics for infantile colic
144. Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections
145. Oral zinc for the prevention of hyperbilirubinemia in neonates
146. Ozone therapy for treating diabetic foot ulcers
147. Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapy
148. Perioperative antioxidants for adults undergoing elective non‐cardiac surgery
149. Pharmacological interventions for self‐harm in adults
150. Physical activity for improving the symptoms of attention deficit hyperactivity disorder in children and adolescents
151. Physical interventions (orthoses, splints, exercise and manual therapy) for treating plantar heel pain
152. Phytoestrogens in the treatment of postmenopausal osteoporosis
153. Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy and food hypersensitivity
154. Preschool and school-based mindfulness programmes for improving mental health and cognitive functioning in young people aged 3 to 18 years
155. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection
156. Probiotics for fibromyalgia
157. Probiotics for preventing urinary tract infections in adults and children
158. Probiotics for preventing ventilator-associated pneumonia
159. Probiotics for the post-operative management of term neonates after gastrointestinal surgery
160. Probiotics for the prevention of Hirschsprung‐associated enterocolitis
161. Probiotics for the prevention or treatment of hyperbilirubinaemia in late preterm and term neonates
162. Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults
163. Psychodynamic therapies versus treatment as usual for depression
164. Qigong for the primary prevention of cardiovascular disease
165. Reflexology for treatment of constipation
166. Reiki treatment for psychological symptoms
167. Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome
168. Selenium supplementation during pregnancy for improving maternal and newborn outcomes
169. Singing for people with Parkinson's disease
170. Spiritual and religious interventions for adults with cancer and their carers: an overview of systematic reviews
171. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates
172. Synbiotics, prebiotics and probiotics for people with chronic kidney disease
173. Systemic nutritional interventions for treating foot ulcers in people with diabetes
174. Tai Chi for hypertension
175. Tai Chi for improving recovery after stroke
176. Tai chi for schizophrenia
177. Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders
178. Testosterone supplementation for mild cognitive impairment and dementia
179. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention
180. Topical herbal interventions for gingivitis
181. Traditional Chinese medicinal herbs for condyloma acuminatum
182. Transcranial direct current stimulation (tDCS) for improving fatigue, motor function, and pain in people with multiple sclerosis
183. Transcranial laser therapy for acute ischemic stroke
184. Transcranial magnetic stimulation for schizophrenia
185. Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain
186. Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea
187. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
188. Vitamin A supplementation for postpartum women
189. Vitamin A supplementation for prevention of mortality and morbidity in moderate and late preterm infants
190. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid life
191. Vitamin B for treating diabetic peripheral neuropathy
192. Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults
193. Vitamin D for the management of chronic obstructive pulmonary disease
194. Vitamin D supplementation in infancy for improving bone density
195. Vitamin D with or without calcium for treating osteoporosis in postmenopausal women
196. Vitamin E supplementation for adults with diabetes mellitus
197. Vitamin K for the prevention and treatment of osteoporosis in post-menopausal women
198. Vitamin K for the primary prevention of cardiovascular disease
199. Workplace lighting for improving mood and alertness in daytime workers
200. Xylitol-containing products for preventing dental caries in children and adolescents
201. Yoga for schizophrenia
202. Yoga for stroke rehabilitation